Short-term Course of PDA in Preterm Infants with RDS and Factors Associated with its Persistence

Background: Patent ductus arteriosus (PDA) refers to the continued existence postnatally of the fetal link (ductus arteriosus) connecting the aorta and the pulmonary artery. Objective: determine whether the surfactant replacement therapy used for the treatment of respiratory distress syndrome (RDS) is affecting the incidence and/or the closure of PDA. Also to study the different treatment strategies for RDS and PDA and its effects on the PDA closure in preterm infants. Methods: A prospective observational study done in the neonatal intensive care unit in a tertiary center in Baghdad, Iraq. The study was conducted from July 2024 to February 2025. The patients included in the study are all preterm infants less than 37 weeks' gestational age who were diagnosed with RDS and treated for that by either nasal continuous positive airway pressure (CPAP), mechanical ventilation (MV), or both. Results: 43 preterm infants were included with a median gestational age at labor of 30 (IQR=8-33) weeks; birth weight ranged between 750 and 2250 grams with a median of 1400 grams (IQR=1100-1900). Males were the dominant contributor, accounting for 60.5%. Only 20.9% of infants were breastfed, 46.5% were on formula, and 32.6% received mixed feeding. The closure of PDA occurred in 15 (34.9%) infants, while closure failed (persistent PDA) in 10 (23.3%) and 18 (41.9%) remained with no PDA. Conclusions: There was no difference in the treatment of PDA between infants who received surfactant and those who received respiratory support with NCPAP or MV, despite the increased number of closed PDAs in treated infants; however, there was a significant difference in PDA closure based on whether the infants received treatment.

Authors

Institutions

Publication Details

Journal
Al-Rafidain Journal of Medical Sciences
Published
2026-11-17
DOI
https://doi.org/10.54133/ajms.v11i2.3405
Primary Topic
Cardiovascular Conditions and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Short-term Course of PDA in Preterm Infants with RDS and Factors Associated with its Persistence

Munaf Jarallah Yaseen, Nabeeha Najatee Akram, Yasir Ibrahim Abdulridha, Sura Abd Alwahab Al-Bermany
Al-Rafidain Journal of Medical Sciences
Cardiovascular Conditions and Treatments
article

Short-term Course of PDA in Preterm Infants with RDS and Factors Associated with its Persistence

Munaf Jarallah Yaseen, Nabeeha Najatee Akram, Yasir Ibrahim Abdulridha, Sura Abd Alwahab Al-Bermany
article en

Abstract

Background: Patent ductus arteriosus (PDA) refers to the continued existence postnatally of the fetal link (ductus arteriosus) connecting the aorta and the pulmonary artery. Objective: determine whether the surfactant replacement therapy used for the treatment of respiratory distress syndrome (RDS) is affecting the incidence and/or the closure of PDA. Also to study the different treatment strategies for RDS and PDA and its effects on the PDA closure in preterm infants. Methods: A prospective observational study done in the neonatal intensive care unit in a tertiary center in Baghdad, Iraq. The study was conducted from July 2024 to February 2025. The patients included in the study are all preterm infants less than 37 weeks' gestational age who were diagnosed with RDS and treated for that by either nasal continuous positive airway pressure (CPAP), mechanical ventilation (MV), or both. Results: 43 preterm infants were included with a median gestational age at labor of 30 (IQR=8-33) weeks; birth weight ranged between 750 and 2250 grams with a median of 1400 grams (IQR=1100-1900). Males were the dominant contributor, accounting for 60.5%. Only 20.9% of infants were breastfed, 46.5% were on formula, and 32.6% received mixed feeding. The closure of PDA occurred in 15 (34.9%) infants, while closure failed (persistent PDA) in 10 (23.3%) and 18 (41.9%) remained with no PDA. Conclusions: There was no difference in the treatment of PDA between infants who received surfactant and those who received respiratory support with NCPAP or MV, despite the increased number of closed PDAs in treated infants; however, there was a significant difference in PDA closure based on whether the infants received treatment.

Al-Rafidain Journal of Medical SciencesVol. 11(2)
University of Baghdad (IQ), Mustansiriyah University (IQ)
Cardiovascular Conditions and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon